You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,489,329


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,489,329
Title: Pharmaceutical compositions for the treatment of rhinitis
Abstract:A pharmaceutical composition comprising a therapeutically effective amount of a mixture consisting essentially of (i) pseudoephedrine, an individual optical isomer or a pharmaceutically acceptable salt thereof, and (ii) at least one compound selected from 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acid or amide derivatives, an individual optical isomer or a pharmaceutically acceptable salt thereof.
Inventor(s): van de Venne; Herman (Lasne, BE), Martin; Jean-Pierre (Montigny-Le-Tilleul, BE)
Assignee: UCB S.A. (Brussels, BE)
Application Number:09/838,190
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,489,329: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 6,489,329, focusing on its scope, claims, and the broader patent landscape.

Overview of United States Patent 6,489,329

Patent Number and Title

United States Patent 6,489,329 B2, titled "Pharmaceutical Compositions," was granted to address specific needs in the pharmaceutical industry. This patent is part of a larger body of intellectual property related to pharmaceutical formulations.

Inventors and Assignees

Identifying the inventors and assignees is essential for understanding the ownership and potential licensing or collaboration opportunities. The patent document lists the inventors and the assignee, which could be a company or an individual[5].

Filing and Grant Dates

The filing date and grant date are critical for determining the patent's validity period and any potential prior art. The patent was granted on December 3, 2002, after being filed on a specific date that can be found in the patent document[5].

Scope of the Patent

Background of the Invention

The background section of the patent provides context about the existing state of the art and the problems the invention aims to solve. For US 6,489,329, this section likely discusses the limitations of previous pharmaceutical compositions and the need for improved formulations[5].

Summary of the Invention

The summary section outlines the main aspects of the invention, including its key components, methods of preparation, and intended uses. This section is crucial for understanding the broad scope of what the patent covers[5].

Claims of the Patent

Independent and Dependent Claims

Patent claims are the most critical part of a patent as they define the scope of protection. US 6,489,329 includes both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[5].

Claim Analysis

  • Claim 1: Typically the broadest independent claim, it sets the foundation for the invention.
  • Dependent Claims: These claims narrow down the scope by adding specific limitations or features to the independent claims.
  • Claim Language: The language used in the claims is precise and technical, ensuring that the scope of protection is clearly defined.

Patent Landscape Analysis

Prior Art and Related Patents

To understand the position of US 6,489,329 within the patent landscape, it is necessary to conduct a thorough search of prior art and related patents. Tools like the USPTO's Patent Public Search, Global Dossier, and international databases such as Espacenet and Patentscope can be used to identify similar patents and applications[1][4].

Competitor Patents

Analyzing competitor patents helps in identifying gaps and opportunities in the market. This involves comparing the claims, scope, and innovations of similar patents to determine how US 6,489,329 stands out.

International Patent Family

Using resources like the Global Dossier, one can identify the patent family for US 6,489,329, including related applications filed in other countries. This provides a global perspective on the patent's protection and potential for international collaboration or licensing[1].

Search Tools and Resources

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching U.S. patents and published patent applications. It offers enhanced access to prior art and is a key tool for conducting preliminary patent searches[1].

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related citations[1].

International Patent Databases

Databases such as Espacenet (European Patent Office), Patentscope (WIPO), and national patent offices' databases are essential for a global patent landscape analysis. These resources offer full-text searches and machine translations for some documents[1][4].

Economic and Strategic Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into the scope and value of patents. This dataset includes detailed information on claims from U.S. patents and applications, helping in the analysis of patent scope and relative value[3].

Market Impact

Understanding the scope and claims of US 6,489,329 can help businesses assess its market impact. This includes evaluating the potential for licensing, collaboration, or competition in the pharmaceutical industry.

Legal Considerations

Patent Validity and Enforcement

Ensuring the validity of the patent and understanding the legal framework for enforcement are critical. This involves reviewing office actions, citations, and any legal challenges to the patent[1].

Patent Assignment and Ownership

The Patent Assignment Search tool can be used to track changes in ownership, which is vital for licensing agreements and legal disputes[1].

Conclusion

Analyzing the scope and claims of United States Patent 6,489,329 requires a thorough understanding of the patent document, the broader patent landscape, and the use of various search tools and resources. By leveraging these tools and resources, businesses and inventors can gain valuable insights into the strength and relative value of the patent.

Key Takeaways

  • Patent Scope: Understanding the background, summary, and claims of the patent is essential for determining its scope.
  • Claims Analysis: Independent and dependent claims define the protection scope.
  • Patent Landscape: Conduct thorough searches using USPTO and international databases to identify prior art and related patents.
  • Economic Implications: Use datasets like the Patent Claims Research Dataset to assess patent value.
  • Legal Considerations: Ensure patent validity and track ownership changes.

FAQs

Q: How do I search for prior art related to US 6,489,329?

A: Use the USPTO's Patent Public Search tool, Global Dossier, and international databases like Espacenet and Patentscope to search for prior art and related patents.

Q: What is the significance of the Global Dossier in patent searching?

A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family and related citations in one place.

Q: How can I determine the market impact of US 6,489,329?

A: Analyze the patent's claims, review industry trends, and use datasets like the Patent Claims Research Dataset to assess its market value and potential.

Q: What tools can I use to track changes in patent ownership?

A: The Patent Assignment Search tool on the USPTO website allows you to search for patent assignments and changes in ownership.

Q: Why is it important to analyze the claims of a patent?

A: The claims define the scope of protection for the patent, and analyzing them helps in understanding what is protected and what is not.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Harvard Business School Library - Patent search: A comparative table of databases: https://asklib.library.hbs.edu/faq/266950
  5. United States Patent 6,489,329 B2: https://patentimages.storage.googleapis.com/cd/43/20/26518cf8c638dc/US6489329.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,489,329

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,489,329

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1774097 ⤷  Subscribe
Australia 723364 ⤷  Subscribe
Brazil 9701686 ⤷  Subscribe
Colombia 4820432 ⤷  Subscribe
United Kingdom 2311940 ⤷  Subscribe
United Kingdom 9706842 ⤷  Subscribe
Guatemala 199700037 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.